​
​

Sutro Biopharma (STRO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Sutro Biopharma Revenue Highlights

Latest Revenue (Y)

$153.73M

Latest Revenue (Q)

$25.71M

Main Segment (Y)

Collaboration Revenue

Main Geography (Y)

Collaboration Revenue

Sutro Biopharma Revenue by Period

Sutro Biopharma Revenue by Year

DateRevenueChange
2023-12-31$153.73M126.84%
2022-12-31$67.77M9.52%
2021-12-31$61.88M44.84%
2020-12-31$42.72M-0.03%
2019-12-31$42.74M11.24%
2018-12-31$38.42M-25.75%
2017-12-31$51.74M-13.38%
2016-12-31$59.73M-

Sutro Biopharma generated $153.73M in revenue during NA 2023, up 126.84% compared to the previous quarter, and up 400.14% compared to the same period a year ago.

Sutro Biopharma Revenue by Quarter

DateRevenueChange
2024-06-30$25.71M97.62%
2024-03-31$13.01M-88.56%
2023-12-31$113.72M571.95%
2023-09-30$16.92M62.54%
2023-06-30$10.41M-17.85%
2023-03-31$12.67M46.83%
2022-12-31$8.63M-65.67%
2022-09-30$25.15M-10.50%
2022-06-30$28.10M376.45%
2022-03-31$5.90M-44.65%
2021-12-31$10.65M25.09%
2021-09-30$8.52M-69.64%
2021-06-30$28.05M91.33%
2021-03-31$14.66M77.10%
2020-12-31$8.28M-53.55%
2020-09-30$17.82M88.22%
2020-06-30$9.47M32.40%
2020-03-31$7.15M-36.74%
2019-12-31$11.30M-7.92%
2019-09-30$12.28M16.65%
2019-06-30$10.53M21.97%
2019-03-31$8.63M-54.79%
2018-12-31$19.09M143.57%
2018-09-30$7.84M37.38%
2018-06-30$5.70M-1.54%
2018-03-31$5.79M43.39%
2017-12-31$4.04M-76.91%
2017-09-30$17.50M15.88%
2017-06-30$15.10M-
2017-03-31$15.10M-

Sutro Biopharma generated $25.71M in revenue during Q2 2024, up 97.62% compared to the previous quarter, and up 202.82% compared to the same period a year ago.

Sutro Biopharma Revenue Breakdown

Sutro Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 18
Other Revenue$5.42M
Collaboration Revenue$13.54M

Sutro Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 18: Collaboration Revenue (71.40%), and Other Revenue (28.60%).

Quarterly Revenue by Product

Product/ServiceDec 18Sep 18
Other Revenue$654.00K$912.00K
Collaboration Revenue$18.43M-

Sutro Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Dec 18: Collaboration Revenue (96.57%), and Other Revenue (3.43%).

Sutro Biopharma Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 18
Collaboration Revenue$13.54M
Other Revenue$5.42M

Sutro Biopharma's latest annual revenue breakdown by geography, as of Dec 18: Collaboration Revenue (71.40%), and Other Revenue (28.60%).

Quarterly Revenue by Country

CountryDec 18Sep 18
Other Revenue$654.00K$912.00K
Collaboration Revenue$18.43M-

Sutro Biopharma's latest quarterly revenue breakdown by geography, as of Dec 18: Collaboration Revenue (96.57%), and Other Revenue (3.43%).

Sutro Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
STROSutro Biopharma$153.73M$25.71M
MRUSMerus$43.95M$11.77M
IDYAIDEAYA Biosciences$23.39M-
ANABAnaptysBio$17.16M$30.02M
MGTXMeiraGTx$14.02M$10.91M
CNTACentessa Pharmaceuticals$6.88M-
FIXXQ32 Bio$1.16M-
KROSKeros Therapeutics$151.00K$37.00K
OPTOpthea$108.41K$61.27K
PCVXVaxcyte--
AVTEAerovate Therapeutics--
REPLReplimune Group--
ELYMEliem Therapeutics--
SNDXSyndax Pharmaceuticals-$12.50M
MLYSMineralys Therapeutics--
LRMRLarimar Therapeutics--
PRDSPardes Biosciences--
HLVXHilleVax--
GNTAGenenta Science S.p.A.--

STRO Revenue FAQ

What is Sutro Biopharma’s yearly revenue?

Sutro Biopharma's yearly revenue for 2023 was $153.73M, representing an increase of 126.84% compared to 2022. The company's yearly revenue for 2022 was $67.77M, representing an increase of 9.52% compared to 2021. STRO's yearly revenue for 2021 was $61.88M, representing an increase of 44.84% compared to 2020.

What is Sutro Biopharma’s quarterly revenue?

Sutro Biopharma's quarterly revenue for Q2 2024 was $25.71M, a 97.62% increase from the previous quarter (Q1 2024), and a 146.89% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $13.01M, a -88.56% decrease from the previous quarter (Q4 2023), and a 2.64% increase year-over-year (Q1 2023). STRO's quarterly revenue for Q4 2023 was $113.72M, a 571.95% increase from the previous quarter (Q3 2023), and a 1217.44% increase year-over-year (Q4 2022).

What is Sutro Biopharma’s revenue growth rate?

Sutro Biopharma's revenue growth rate for the last 3 years (2021-2023) was 148.43%, and for the last 5 years (2019-2023) was 259.72%.

What are Sutro Biopharma’s revenue streams?

Sutro Biopharma's revenue streams in c 18 are Other Revenue, and Collaboration Revenue. Other Revenue generated $5.42M in revenue, accounting 28.60% of the company's total revenue Collaboration Revenue generated $13.54M in revenue, accounting 71.40% of the company's total revenue

What is Sutro Biopharma’s main source of revenue?

For the fiscal year ending Dec 18, the largest source of revenue of Sutro Biopharma was Collaboration Revenue. This segment made a revenue of $13.54M, representing 71.40% of the company's total revenue.